Aurora Kinase/Cdk Inhibitor (JNJ-7706621) a cell-permeable, reversible, ATP-competitive kinase inhibitor

Aurora Kinase/Cdk Inhibitor  (CAS 443797-96-4)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 111ms
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Synonym: JNJ-7706621, 4-(5-Amino-1-(2,6-difluorobenzoyl)-1H-[1,2,4]triazol-3-ylamino)-benzenesulfonamide
Application: (JNJ-7706621) a cell-permeable, reversible, ATP-competitive kinase inhibitor
CAS Number: 443797-96-4
Purity: ≥97%
Molecular Weight: 435.4
Molecular Formula: C15H12F2N6O3S CH3CN
* Refer to Certificate of Analysis for lot specific data (including water content).
Submit a review for this product and receive 15 CruzCredits

Ordering Information

Aurora Kinase/Cdk Inhibitor sc-203829 5 mg $440.00

Aurora Kinase/Cdk inhibitor (JNJ-7706621) is a cell-permeable triazolylsulfonamido compound that acts as a reversible, ATP-competitive kinase inhibitor with selectivity towards ARKs (IC50 = 11 and 15 nM for ARK-1 (Aurora-A) and ARK-2 (Aurora-B), respectively) and Cdk's (IC50 = 9, 4, and 3 nM for Cdc2 (Cdk1)/B, Cdk2/A, and Cdk2/E, respectively). Aurora Kinase/Cdk Inhibitor displays antitumor properties (IC50 in the range of 112-514 nM against various human cancer cell lines).


1. Emanuel, S. et al. 2005. Cancer Res. 65(19): 9038-9046. PMID: 16204078
2. Lin, R. et al. 2005. J. Med. Chem. 48(13): 4208-4211. PMID: 15974571
3. Seamon, J.A. et al. 2006. Mol. Cancer Ther. 5(10): 2459-2467. PMID: 17041089

Physical State :
Solubility :
Soluble in DMSO.
Storage :
Store at 4° C
IC50 :
Aurora-A: IC50 = 11 nM; Aurora-B: IC50 = 15 nM; Cdk1/B: IC50 = 9 nM; Cdk2/A: IC50 = 4 nM; Cdk2/E: IC50 = 3 nM; cancer cell lines: IC50 = 112 - 514 nM (human)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

You May Also Like

Does Aurora Kinase/Cdk Inhibitor contain acetonitrile?

Asked by: ChemSynth123
Thank you for your question. Aurora Kinase/Cdk Inhibitor, sc-203829, is a complex comprised of acetonitrile and 4-(5-Amino-1-(2,6-difluorobenzoyl)-1H-[1,2,4]triazol-3-ylamino)-benzenesulfonamide.
Answered by: TechService7
Date published: 2017-01-24
  • y_2017, m_9, d_19, h_6CST
  • bvseo_bulk, prod_bvqa, vn_bulk_2.0.3
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_203829, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 92ms
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 8ms
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2017 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.